Immune response to virus-infection-associated (VIA) antigen in cattle repeatedly vaccinated with foot-and-mouth disease virus inactivated by formalin or acetylethyleneimine

SUMMARY The results of experiments to investigate antibody to ‘virus infection associated’ (VIA) antigen in cattle repeatedly vaccinated with formalin- or acetylethyleneimine- (AEI) inactivated foot-and-mouth disease (FMD) vaccines under laboratory conditions are reported. Results are also presented from some vaccinated animals subsequently exposed to FMD infection. Antibody against VIA was not detected before and after the first vaccination with formalin or AEI-inactivated vaccine but did develop in all animals after the second formalin vaccination and persisted throughout the experiment. After the second AEI vaccination, 4 of 12 animals developed antibody which persisted for at least 37 days. This transient response in some cattle was repeated after successive vaccinations but, in general, more animals responded as the number of vaccinations increased. After exposure to infection, a transient VIA antibody response was occasionally observed in immune AEI-vaccinated animals. Some immune repeatedly AEI-vaccinated cattle did not develop detectable VIA antibody after challenge despite the persistence of virus in oesophageal–pharyngeal (O/P) fluid. The presence of antibody to VIA antigen is not conclusive proof that vaccinated animals have been exposed to infection and field data must be interpreted with caution.

[1]  P. Dawe,et al.  Antibody responses to type-specific and "virus-infection-associated" antigens in cattle vaccinated with inactivated polyvalent foot and mouth disease virus in North Malawi. , 1978, The British veterinary journal.

[2]  S. Golding,et al.  Radial immuno-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular disease. , 1976, Research in veterinary science.

[3]  P. Sutmoller,et al.  Foot-and-mouth disease: the agar gel diffusion precipitin test for antibody to virus-infection-associated (via) antigen as a tool for epizootiologic surveys. , 1970, American journal of epidemiology.

[4]  D. Rowlands,et al.  Evidence for an internal antigen in foot-and-mouth disease virus. , 1969, The Journal of general virology.

[5]  J. Graves,et al.  A third antigenic component associated with foot-and-mouth disease infection. , 1966, Virology.

[6]  W. Snowdon.  Growth of Foot-and-Mouth Disease Virus in Monolayer Cultures of Calf Thyroid Cells , 1966, Nature.

[7]  Graves Jh.  FORMALDEHYDE INACTIVATION OF FOOT-AND-MOUTH DISEASE VIRUS AS APPLIED TO VACCINE PREPARATION. , 1963 .

[8]  F. Brown,et al.  The use of acetylethyleneimine in the production of inactivated foot-and-mouth disease vaccines , 1963, Journal of Hygiene.

[9]  I. Macpherson,et al.  Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence. , 1962, Virology.

[10]  O. N. Fellowes.  CHEMICAL INACTIVATION OF FOOT‐AND‐MOUTH DISEASE VIRUS , 1960, Annals of the New York Academy of Sciences.

[11]  A. J. Garland,et al.  The inhibitory activity of secretions in cattle against foot and mouth disease virus , 1974 .

[12]  間宮 典久.  骨髄腫の治療効果判定について Radial Immunodiffusion法 , 1970 .